#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Infertility male Immunodeficiency Bronchopulmonary dysplasia Necrotising enterocolitis neonatal Heart disease congenital Thrombocytopenia Congenital leptin deficiency Amyloidosis Malignant peritoneal neoplasm Paget's disease of the vulva Transitional cell cancer of the renal pelvis and ureter Haemophagocytic lymphohistiocytosis Hepatocellular carcinoma Short stature homeobox gene mutation More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Diagnostics Burkitt’s lymphoma – Treatment Urea cycle disorder – Diagnostics Combined immunodeficiency – Treatment Von Willebrand’s disease – Life with Disease Hepatic angiosarcoma Acute respiratory distress syndrome Short-bowel syndrome – Basic Information Rhabdoid tumour – Diagnostics Rosai-Dorfman syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gad20-209-Fsp-A1 Omp12 Argon Dolutegravir Sodium GOCATAMIG Doxecitine Imlifidase Captopril CC-97540 Specific Nucleic Acid Sna-Xfsb Azenosertib Crovalimab Sodium Hyaluronate Folic Acid Dacomitinib Technetium (99Mtc) Ulipristal Acetate Phenol Sotalol Hydrochloride Imipenem Anhydrate More therapies…

    Learn about Your Condition

    Small intestine leiomyosarcoma Pneumococcal infection Shprintzen-Goldberg syndrome Peritoneal abscess Pelizaeus-Merzbacher disease Dizziness Lichen planus Liposarcoma Hypochondroplasia Pancreatitis chronic Myositis Chondrocalcinosis Tuberculosis Large cell lung cancer Oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Lomustine
    • Thiotepa
    • Carboplatin
    Austria Belgium Czechia Denmark Finland Germany +4

  • Study on Valproic Acid, Simvastatin, and Gemcitabine for Untreated Metastatic Pancreatic Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Simvastatin
    • Valproic Acid
    • Capecitabine
    Italy Spain

  • Study on CART 19/22 T Cells and CART45RA-NKG2D Cells for Treating Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Cart 19/22 T Cells
    • Cart45Ra-Nkg2D Cells
    Spain

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1

    Recruiting

    2 1
    Investigated Drugs:
    • Vx-670
    Belgium France Germany Italy The Netherlands Spain

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Children and Young Adults with Blood Cancers or Solid Tumors

    Recruiting

    1 1 1
    Investigated Drugs:
    • Zilovertamab Vedotin
    Belgium Czechia Denmark France Germany Greece +6
Previous Page
1 … 651 652 653 654 655 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!